List of Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
List of Authors
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Hans de Waard
Michael Waddington
K.R. Wadekar
Ruta Waghmare
Mark Wagner
Samir Z. Wahab
Kelly Waldron
Steven Walfish
Marcia Walker
Sue Walker
L. Kevin Wall
Brian Wallace
Edwin G. Walsh
Phyllis Walsh
Gary Walz
Jane Wan
Dr. Weihong Wang
Hong Wang
Jennifer Wang
Peng Wang
Qinggang Wang
Qingxi Wang
Wen Bo Wang
Thomas Warden
Ed Warner
Edward Warner
Tim N. Warner, PhD
Jennifer G. Warren
Vanlee Waters
Keith Watson
Jo Watts
Lloyd Waxman
Harry Way
Larry E. Weaner
Jon Wear
Jim Webber
Bernd Webel
Clinton Weber
Frances Weber
Simon Webster
Jill Wechsler
Thorsten Wedel
Dr. Axel Wehrmann
Andreas Weiler
Jamie Weiss
Kathryn Wekselman
Paul Welitzkin
K. Wells
Richard H. Wendt
Naidong Weng
Jean Pierre Wery
Neal Wesley
Robert Wessman
Elizabeth West
Jo Whelan
Allan Whiston
Karen Whitaker
Chris White
Ed White
Shawn Whitfield
Nathan T. Whitford
Monica Whitmire
Melissa Whitsel
Rich Whitworth
Wolfgang Wienand
Robert Wiens
J. Mark Wiggins
Gary J. Wiley
Kristen D. Wiley
Mr. Neil Wilkinson
Neil Wilkinson
Alison Williams
David J. Williams
Deni Jo Williams
Gerallt Williams
Roger L. Williams, MD
Roger L. Williams
Simon Williams
Zeena Williams
Grant Wilson
Ian Wilson
T. Wilson
Helen Winkle
Helen N. Winkle
Gerhard Winter
William Winter
Conrad Winters
Gwendolyn M. Wise-Blackman
Steve Wisniewski
Krista Witt
Wallace Wittkoff
Peter Wittner
Heinz Wolf
Andrew Wong
Kirby Wong-Moon
Sarah Wood
Peter Woods
Joseph A. Woodward
D. R. Worthen
David Worthen
Back to Top

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
30%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
8%
All of the above.
45%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here